ESC 365 - End-of-trial inflammatory biomarkers, lipid levels, creatine kinase and markers of renal and liver function in the LoDoCo2 trial.

ESC Professional Premium Access

End-of-trial inflammatory biomarkers, lipid levels, creatine kinase and markers of renal and liver function in the LoDoCo2 trial.

Session: Coronary artery disease - Prevention

Topic: Prevention

Speaker: Mrs A. Van Broekhoven (Nijmegen, NL)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Mrs Amber Van Broekhoven

Radboud University Nijmegen, Nijmegen (Netherlands (The))

0 follower

4 more presentations in this session

Ordinal scoring of coronary artery calcification in low dose computed tomography is predictive factor of all-cause death and cardiovascular events.

Speaker: Mr P. Kasprzyk (Gdansk, PL)

Long-term risk factor control after acute coronary syndrome; results from the swedish primary care cardiovascular database

Speaker: Doctor S. Bentzel (Gothenburg, SE)

Statin therapy intensity and physical activity after acute coronary syndrome

Speaker: Mr A. Boudon (Lausanne, CH)

Cardiovascular disease risk in males and females with new onset diabetes: a population-based study in universal health care setting

Speaker: Professor P. Kaul (Edmonton, CA)

Access the full session

Coronary artery disease - Prevention

Speakers: Mrs A. Van Broekhoven, Mr P. Kasprzyk, Doctor S. Bentzel, Mr A. Boudon, Professor P. Kaul

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources